I thank the Senator from Vermont for his leadership. Again, this is the first time in over a decade for the 69 people who aren't on the Appropriations Committee to get to come to the floor and offer amendments and think about what this bill does. Let's talk about some of the things it does. We worked really hard over the last 4 years to do the kinds of things we ought to do in healthcare research. This bill, for the first time, reaches a long-held goal of the national plan to address Alzheimer's disease, of getting those annual research dollars up over $2 billion--in fact, $2.34 billion, exceeding what had been a long-term goal. The goal should not be how much money we spend. It should be finding a way to solve this problem. This is a significant increase over last year. It quadruples where we were 4 years ago. We spent 277 billion tax dollars a year on Alzheimer's and dementia-related care. A lot more private money is spent than that--three times that amount in private money--and there is lost work as caregivers step back to help people with these terrible diseases of dementia and Alzheimer's. But here is $277 billion. So this bill does about 1 percent of that in research to try to solve a problem that taxpayers are overwhelmed by.…
Roy Blunt: “I thank the Senator from Vermont for his leadership. Again, this is the first time in over a decade for the 69 people…”
On the recordAugust 21, 2018
Share
More from Roy Blunt
Sep 26, 2022
... it is the policy of this Nation, in fulfillment of its special trust responsibilities and legal obligations to Indians--to ensure the highest possible health status for Indians and urban Indians and to provide for all resources…
Aug 3, 2022
I want to join my colleagues in my appreciation for the expansion of NATO--as others have said, the greatest alliance, maybe in history, certainly in the last 200 years, an alliance that has served great benefits and now is growing. NATO…
Dec 6, 2023
MCPP is thankful for the strong bipartisan support that the subcommittee leaders, Chairwoman Patty Murray and Ranking Member Roy Blunt, have shown in providing the NIH with its seventh consecutive funding increase during this time of…





